环丙泊酚通过促进MAPK11-PML磷酸化减少胶质瘤术后复发:来自转录组与蛋白质组分析的见解
研究在胶质瘤T98G细胞中给予不同浓度环丙泊酚,用CCK-8、Transwell和流式细胞术检测增殖、侵袭、迁移与凋亡,并行蛋白质组、磷酸化蛋白质组和转录组分析寻找靶点。结果显示环丙泊酚抑制增殖、侵袭和迁移并促进凋亡,MAPK11和PML为其关键介导分子;小鼠模型显示环丙泊酚通过MAPK11-PML磷酸化减少术后复发。
要点
- 环丙泊酚抑制胶质瘤T98G细胞增殖、侵袭和迁移,并促进凋亡。
- MAPK11与PML被鉴定为环丙泊酚作用的关键介导分子。
- 小鼠模型中环丙泊酚经MAPK11-PML磷酸化减少术后复发。
核心结论
- 环丙泊酚通过促进MAPK11-PML磷酸化减少胶质瘤术后复发,为胶质瘤治疗提供新分子靶点,并提示其麻醉之外的治疗潜力。
研究设计与样本
- 体外研究:胶质瘤T98G细胞经不同浓度环丙泊酚处理,采用CCK-8、Transwell和流式细胞术检测。
- 组学分析:进行蛋白质组、磷酸化蛋白质组和转录组分析以识别分子靶点与通路。
- 分子对接评估环丙泊酚与关键激酶的结合,沉默实验验证其作用。
- 体内研究:采用胶质瘤小鼠模型,通过肿瘤大小、荧光成像和组织学分析评估术后复发。
主要发现
- 环丙泊酚抑制胶质瘤细胞增殖、侵袭和迁移,同时促进凋亡。
- 蛋白质组分析鉴定MAPK11和PML为环丙泊酚作用的关键介导分子。
- 沉默MAPK11削弱上述效应。
- 体内实验显示环丙泊酚通过MAPK11-PML磷酸化减少术后复发。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Glioma, the most common malignant tumor of the central nervous system, has a high postoperative recurrence rate. While Ciprofol is widely used as an anesthetic, its therapeutic potential in glioma treatment remains largely unexplored. METHODS: Glioma T98G cells were treated with varying concentrations of Ciprofol to assess proliferation, invasion, migration, and apoptosis via CCK-8, Transwell, and flow cytometry assays. Proteomic, phosphoproteomic, and transcriptomic analyses were performed to identify molecular targets and pathways. Molecular docking evaluated the binding of Ciprofol to key kinases, and silencing experiments validated their roles. In vivo, glioma mouse models were used to assess postoperative recurrence via tumor size, fluorescence imaging, and histological analysis. RESULTS: Ciprofol inhibited glioma cell proliferation, invasion, and migration while promoting apoptosis. Proteomic analyses identified MAPK11 and PML as key mediators of Ciprofol's effects. Silencing MAPK11 impaired these effects, while in vivo experiments showed reduced postoperative recurrence via MAPK11-PML phosphorylation. CONCLUSION: Ciprofol reduces postoperative glioma recurrence by promoting MAPK11-PML phosphorylation, providing novel molecular targets for glioma treatment and suggesting its therapeutic potential beyond anesthesia.
引用
- Li Y, Shi J, Liu C, et al. Ciprofol reduces postoperative glioma recurrence by promoting MAPK11-PML phosphorylation: insights from transcriptomic and proteomic analysis. J Neurooncol. 2025. PMID: 40019711. doi:10.1007/s11060-024-04906-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。